# [Tc-99m]-RPI-087 as an Imaging Marker in Osteoarthritis of the Knee Compared to Healthy Volunteers

> **NCT03503825** · PHASE1 · UNKNOWN · sponsor: **Reiley Pharmaceuticals Inc.** · enrollment: 24 (estimated)

## Conditions studied

- Healthy
- Osteo Arthritis Knee

## Interventions

- **DRUG:** [Tc-99m]-RPI-T-087 Injection

## Key facts

- **NCT ID:** NCT03503825
- **Lead sponsor:** Reiley Pharmaceuticals Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-08-16
- **Primary completion:** 2019-05-31
- **Final completion:** 2019-06-30
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2019-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03503825

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03503825, "[Tc-99m]-RPI-087 as an Imaging Marker in Osteoarthritis of the Knee Compared to Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03503825. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*